Literature DB >> 17315287

Neoadjuvant therapy for pancreatic cancer.

J Kleeff1, H Friess, M W Büchler.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17315287     DOI： 10.1002/bjs.5737

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  11 in total

Review 1.  Improving outcomes in pancreatic cancer: key points in perioperative management.

Authors:  José M Alamo; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Lydia Barrera; Miguel A Gómez; Jordi Muntané; Francisco J Padillo
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 2.  Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.

Authors:  Sonja Gillen; Tibor Schuster; Christian Meyer Zum Büschenfelde; Helmut Friess; Jörg Kleeff
Journal:  PLoS Med       Date:  2010-04-20       Impact factor: 11.069

3.  Inframesocolic Superior Mesenteric Artery First Approach as an Introductory Procedure of Radical Antegrade Modular Pancreatosplenectomy for Carcinoma of the Pancreatic Body and Tail.

Authors:  Suefumi Aosasa; Makoto Nishikawa; Mayumi Hoshikawa; Takuji Noro; Junji Yamamoto
Journal:  J Gastrointest Surg       Date:  2015-11-24       Impact factor: 3.452

4.  Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid.

Authors:  Chiharu Tanaka; Kaoru Furihata; Seiji Naganuma; Mitsunari Ogasawara; Reiko Yoshioka; Hideki Taniguchi; Mutsuo Furihata; Keisuke Taniuchi
Journal:  Hum Cell       Date:  2022-02-12       Impact factor: 4.174

5.  Current state of surgical management of pancreatic cancer.

Authors:  Thilo Hackert; Markus W Büchler; Jens Werner
Journal:  Cancers (Basel)       Date:  2011-03-10       Impact factor: 6.639

6.  Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center.

Authors:  Christoph W Michalski; Jörg Kleeff; Jeannine Bachmann; Jaber Alkhatib; Mert Erkan; Irene Esposito; Ulf Hinz; Helmut Friess; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2007-10-18       Impact factor: 5.344

7.  Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer.

Authors:  Michele Fiore; Lucio Trodella; Sergio Valeri; Domenico Borzomati; Barnaba Floreno; Edy Ippolito; Pasquale Trecca; Luca Eolo Trodella; Rolando Maria D'Angelillo; Sara Ramella; Roberto Coppola
Journal:  Radiat Oncol       Date:  2015-12-15       Impact factor: 3.481

8.  Palliative interventional and surgical therapy for unresectable pancreatic cancer.

Authors:  Volker Assfalg; Norbert Hüser; Christoph Michalski; Sonja Gillen; Jorg Kleeff; Helmut Friess
Journal:  Cancers (Basel)       Date:  2011-02-14       Impact factor: 6.639

9.  Phytotherapeutics Oridonin and Ponicidin show Additive Effects Combined with Irradiation in Pancreatic Cancer in Vitro.

Authors:  Jakob Liermann; Patrick Naumann; Franco Fortunato; Thomas E Schmid; Klaus-Josef Weber; Jürgen Debus; Stephanie E Combs
Journal:  Radiol Oncol       Date:  2017-11-29       Impact factor: 2.991

10.  Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis.

Authors:  Lai Wang; Chien-Shan Cheng; Lianyu Chen; Zhen Chen
Journal:  Cancer Manag Res       Date:  2018-07-05       Impact factor: 3.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.